๐Ÿ‡ฎ๐Ÿ‡ชIreland
16ยฐC Partly Cloudy ยท Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—† Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide โ—† The โ‚ฌ100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany โ—† Ireland's โ‚ฌ93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact โ—† The Pharmacist's Role: How Community Pharmacies in Ireland and the UK Are Adapting as Patients Bypass High-Street Stores for Direct Delivery โ—† GLP-1 Therapeutics and Clinical Research Updates: Brain Reward Mapping, Oral Small Molecules, and Triple-Agonist Horizons โ—† Rinn Pharma & Biopharma Joins NordicPharmaTrain Network to Accelerate European Research & Advanced Manufacturing โ—† Markets Surge as August Opens: $400B Big Pharma Merger Speculation & AstraZeneca Deal Talks Grab Global Headlines โ—† Trumpโ€™s September Visit to Ireland: Agenda, Economic Policy Evaluation & U.S.-Irish Trade Implications โ—†
Updated 04 Jul 2026 ยท HPRA open data

Octocog alfa - Medicines in Ireland

13 authorised products containing Octocog alfa, from the HPRA register.

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0โ€“9
Showing 13 authorised medicines
MedicineActive substanceLicence holderStatus
Kogenate Bayer
EU/1/00/143/002
Octocog alfa Bayer Schering Pharma AG โ€”
Kogenate Bayer
EU/1/00/143/003
Octocog alfa Bayer Schering Pharma AG โ€”
Kogenate Bayer
EU/1/00/143/005
Octocog alfa Bayer Schering Pharma AG โ€”
Kogenate Bayer
EU/1/00/143/006
Octocog alfa Bayer Schering Pharma AG โ€”
Kogenate Bayer
EU/1/00/143/012-013
Octocog alfa Bayer Schering Pharma AG โ€”
Kogenate Bayer
EU/1/00/143/10-11
Octocog alfa Bayer Schering Pharma AG โ€”
KOGENATE Bayer
EU/1/00/143/001
Octocog alfa, R-dna (baby hamster kidney expression system) Bayer AG โ€”
KOGENATE BAYER
EU/1/00/143/004
Octocog alfa Bayer Schering Pharma AG โ€”
Kovaltry 1000 IU powder and solvent for solution for injection
EU/1/15/1076/006
Octocog alfa Bayer Pharma AG โ€”
Kovaltry 2000 IU powder and solvent for solution for injection
EU/1/15/1076/008
Octocog alfa Bayer Pharma AG โ€”
Kovaltry 250 IU powder and solvent for solution for injection
EU/1/15/1076/002
Octocog alfa Bayer AG โ€”
Kovaltry 3000 IU powder and solvent for solution for injection
EU/1/15/1076/010
Octocog alfa Bayer Pharma AG โ€”
Kovaltry 500 IU powder and solvent for solution for injection
EU/1/15/1076/004
Octocog alfa Bayer Pharma AG โ€”
Cite this database

Priya Life Science (2026). Irish Medicines Database. Available at: https://priyalifescience.com/medicines (Accessed: 12 August 2026).

Data: Health Products Regulatory Authority (HPRA) open dataset (โ€œAuthorised or Transfer Pending Productsโ€), licensed CC BY 4.0, refreshed daily. Regulatory information only โ€” not medical advice.